|
第七章 參考文獻
1.Ahmmed GU, Dong PH, Song G, Ball NA, Xu Y, Walsh RA, and Chiamvimonvat N:Changes in Ca2+ cycling proteins underlie cardiac action potential prolongation in a pressure-overloaded guinea pig model with cardiac hypertrophy and failure. Circ Res 86: 558-570, 2000. 2.Armoundas AA, Hobai IA, Tomaselli GF, Winslow RL, and O'Rourke B:Role of sodium-calcium exchanger in modulating the action potential of ventricular myocytes from normal and failing hearts. Circ Res 93: 46-53, 2003. 3.Bers DM:Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002. 4.Chen YJ, CS, Yeh HI , Chang MS and Lin CI:Electrophysiology of single cardiomyocytes isolated from rabbit pulmonary veins: implication in initiation of focal atrial fibrillation. Basic Res Cardiol 97: 26-34, 2002. 5.Cheng CP, Loh YX, Lai YJ, Chen YC, H.K. and Lin CI in:Electrophysiological Characteristics of Ventricular Myocytes Obtained from Xin Deficient Mouse Hearts. MSc.thesis. NDMC, 2005. 6.Cheng CP, Loh YX, Lin CI , Lai YJ , Chen YC, Sytwu HK , Gustafson-Wagner EA and Lin J.J-C:Electrophysiological characteristics of ventricular myocytes of Xinα-deficient mice. in: Advances in Heart Disease-Proceedings of the 12th World Congress on Heart Disease. New Trends in Reasearch, Diagnosis and Treatment., edited by Asher Kimchi, Medimond,srl, Bologna, Italy, 2006, pp.25-30. 7.Cherepanova O, Orlova A, Galkin VE, van der Ven PF, Furst DO, Jin JP, and Egelman EH:Xin-repeats and nebulin-like repeats bind to F-actin in a similar manner. J Mol Biol 356: 714-723, 2006. 8.Cribbs LL, Martin BL, Schroder EA, Keller BB, Delisle BP, and Satin J: Identification of the T-type calcium channel (Ca(v)3.1d) in developing mouse heart. Circ Res 88: 403-407, 2001. 9.Danik SB, Liu F, Zhang J, Suk HJ, Morley GE, Fishman GI, and Gutstein DE:Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res 95: 1035-1041, 2004. 10.Despa S, Islam MA, Weber CR, Pogwizd SM, and Bers DM:Intracellular Na+ concentration is elevated in heart failure but Na/K pump function is unchanged. Circulation 105: 2543-2548, 2002. 11.Droogmans G and Nilius B:Kinetic properties of the cardiac T-type calcium channel in the guinea-pig. J Physiol 419: 627-650, 1989. 12.Dupont E, Matsushita T, Kaba RA, Vozzi C, Coppen SR, Khan N, Kaprielian R, Yacoub MH, and Severs NJ:Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol 33: 359-371, 2001. 13.Gilmour RF and Zipes DP:Afterdepolarizations, triggered rhythms and cardiac arrhythmias. in Molecular Physiology and Pharmacology of Cardiac Ion Channel and Transporters.edited by Morad M., Ebashi S., Trautwein W., and Kurachi Y., Kluwer Academic Pub., Dordrecht, Boston, 1996, pp.333-342. 14.Glasser SP:The relevance of T-type calcium antagonists: a profile of mibefradil. J Clin Pharmacol 38: 659-669, 1998. 15.Go A, Srivastava S, Collis L, Coetzee WA, and Artman M:Negative inotropic effect of nifedipine in the immature rabbit heart is due to shortening of the action potential. Pediatr Res 57: 399-403, 2005. 16.Gray RP, McIntyre H, Sheridan DS, and Fry CH.:Intracellular sodium and contractile function in hypertrophied human and guinea-pig myocardium. Pflugers Arch 442: 117-123, 2001. 17.Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, Holubarsch C, Posival H, Just H, and Drexler H:Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium. Circ Res 75: 434-442, 1994. 18.Henderson SA, Goldhaber JI, So JM, Han T, Motter C, Ngo A, Chantawansri C, Ritter MR, Friedlander M, Nicoll DA, Frank JS, Jordan MC, Roos KP, Ross RS, and Philipson KD:Functional adult myocardium in the absence of Na+-Ca2+ exchange: cardiac-specific knockout of NCX1. Circ Res 95: 604-611, 2004. 19.Hilgemann DW, Matsuoka S, Nagel GA, and Collins A:Steady-state and dynamic properties of cardiac sodium-calcium exchange. Sodium-dependent inactivation. J Gen Physiol 100: 905-932, 1992. 20.Houser SR, Piacentino V, 3rd, and Weisser J:Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol 32: 1595-1607, 2000. 21.Jinglin Zeng YR:Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence. Biophys J 68: 949-964, 1995. 22.Kaab S, Dixon J, Duc J, Ashen D, Nabauer M, Beuckelmann DJ, Steinbeck G, McKinnon D, and Tomaselli GF:Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 98: 1383-1393, 1998. 23.Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, Marban E, and Tomaselli GF:Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 78: 262-273, 1996. 24.Kaprielian R, Wickenden AD, Kassiri Z, Parker TG, Liu PP, and Backx PH:Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction. J Physiol 517 ( Pt 1): 229-245, 1999. 25.Kiss E, Ball NA, Kranias EG, and Walsh RA:Differential changes in cardiac phospholamban and sarcoplasmic reticular Ca2+-ATPase protein levels. Effects on Ca2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circ Res 77: 759-764, 1995. 26.Kostetskii I, Li J, Xiong Y, Zhou R, Ferrari VA, Patel VV, Molkentin JD, and Radice GL:Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure. Circ Res 96: 346-354, 2005. 27.Kostin S, Hein S, Arnon E, Scholz D, and Schaper J:The cytoskeleton and related proteins in the human failing heart. Heart Fail Rev 5: 271-280, 2000. 28.Kuo HC, Cheng CF, Clark RB, Lin JJ, Lin JL, Hoshijima M, Nguyen-Tran VT, Gu Y, Ikeda Y, Chu PH, Ross J, Giles WR, and Chien KR:A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of Ito and confers susceptibility to ventricular tachycardia. Cell 107: 801-813, 2001. 29.Lebeche D, Kaprielian R, and Hajjar R:Modulation of action potential duration on myocyte hypertrophic pathways. J Mol Cell Cardiol 40: 725-735, 2006. 30.Li J, Patel VV, Kostetskii I, Xiong Y, Chu AF, Jacobson JT, Yu C, Morley GE, Molkentin JD, and Radice GL:Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesis. Circ Res 97: 474-481, 2005. 31.Lin J.J-C, Gustafson-Wagner EA, Sinn HW , Choi SJ, Jaacks SM, Wang DZ , Evans S. , and Lin J. L-C:Structure, expression, and function of a novel intercalated disc protein, Xin. J Med Sci 25: 215-222, 2005. 32.Luo CH and Rudy Y:A dynamic model of the cardiac ventricular action potential. II. Afterdepolarizations, triggered activity, and potentiation. Circ Res 74: 1097-1113, 1994. 33.Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L, and Harvey RP:Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 9: 1654-1666, 1995. 34.Matsushita T, Oyamada M, Fujimoto K, Yasuda Y, Masuda S, Wada Y, Oka T, and Takamatsu T:Remodeling of cell-cell and cell-extracellular matrix interactions at the border zone of rat myocardial infarcts. Circ Res 85: 1046-1055, 1999. 35.McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, Norman M, Baboonian C, Jeffery S, and McKenna WJ:Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355: 2119-2124, 2000. 36.McNair WP, Ku L, Taylor MR, Fain PR, Dao D, Wolfel E, and Mestroni L: SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 110: 2163-2167, 2004. 37.Meszaros J, Khananshvili D, and Hart G:Mechanisms underlying delayed afterdepolarizations in hypertrophied left ventricular myocytes of rats. Am J Physiol Heart Circ Physiol 281: H903-914, 2001. 38.Mitra R and Morad M:Two types of calcium channels in guinea pig ventricular myocytes. Proc Natl Acad Sci U S A 83: 5340-5344, 1986. 39.Nabauer M, Beuckelmann DJ, and Erdmann E:Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res 73: 386-394, 1993. 40.Nuss HB and Houser SR:T-type Ca2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 73: 777-782, 1993. 41.Pacholsky D, Vakeel P, Himmel M, Lowe T, Stradal T, Rottner K, Furst DO, and van der Ven PF:Xin repeats define a novel actin-binding motif. J Cell Sci 117: 5257-5268, 2004. 42.Papadatos GA, Wallerstein PM, Head CE, Ratcliff R, Brady PA, Benndorf K, Saumarez RC, Trezise AE, Huang CL, Vandenberg JI, Colledge WH, and Grace AA: Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci U S A 99: 6210-6215, 2002. 43.Pashmforoush M, Lu JT, Chen H, Amand TS, Kondo R, Pradervand S, Evans SM, Clark B, Feramisco JR, Giles W, Ho SY, Benson DW, Silberbach M, Shou W, and Chien KR:Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117: 373-386, 2004. 44.Perriard JC, Hirschy A, and Ehler E:Dilated cardiomyopathy: a disease of the intercalated disc? Trends Cardiovasc Med 13: 30-38, 2003. 45.Peters NS, Green CR, Poole-Wilson PA, and Severs NJ:Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 88: 864-875, 1993. 46.Pogwizd SM and Bers DM:Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc Med 14: 61-66, 2004. 47.Pogwizd SM, Qi M, Yuan W, Samarel AM, and Bers DM:Upregulation of Na+/Ca2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res 85: 1009-1019, 1999. 48.Pogwizd SM, Schlotthauer K, Li L, Yuan W, and Bers DM:Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 88: 1159-1167, 2001. 49.Pogwizd SM, Sipido KR, Verdonck F, and Bers DM:Intracellular Na in animal models of hypertrophy and heart failure: contractile function and arrhythmogenesis. Cardiovasc Res 57: 887-896, 2003. 50.Reuter H, Pott C, Goldhaber JI, Henderson SA, Philipson KD, and Schwinger RH:Na+--Ca2+ exchange in the regulation of cardiac excitation-contraction coupling. Cardiovasc Res 67: 198-207, 2005. 51.Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, Friedl A, and Bleese N:Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 83: 504-514, 1991. 52.Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, and Seidman JG:Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281: 108-111, 1998. 53.Schultheiss TM, Burch JB, and Lassar AB:A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev 11: 451-462, 1997. 54.Schwinger RH, Bohm M, Schmidt U, Karczewski P, Bavendiek U, Flesch M, Krause EG, and Erdmann E:Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92: 3220-3228, 1995. 55.Sinn HW, Balsamo J, Lilien J, and Lin JJ:Localization of the novel Xin protein to the adherens junction complex in cardiac and skeletal muscle during development. Dev Dyn 225: 1-13, 2002. 56.Swynghedauw B, Levy B, Tedgui A, Sanders MR, Kostis JB, Ostadl B, Kolar F, Schunkert H, Riegger GAJ, Malliani A, Benlian P and Young P:Ion basis of resting and action potential. in : Cardiac Cellular Electrophysiology. edited by Carmeliet E, Vereecke J, Kluwer Academic Publishers, Boston, 2002, pp.95-178 57.Tomaselli GF and Marban E:Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 42: 270-283, 1999. 58.Triggle DJ:The physiological and pharmacological significance of cardiovascular T-type, voltage-gated calcium channels. Am J Hypertens 11: 80S-87S, 1998. 59.van Rijen HV, Eckardt D, Degen J, Theis M, Ott T, Willecke K, Jongsma HJ, Opthof T, and de Bakker JM:Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation 109: 1048-1055, 2004. 60.van Veen TA, Stein M, Royer A, Le Quang K, Charpentier F, Colledge WH, Huang CL, Wilders R, Grace AA, Escande D, de Bakker JM, and van Rijen HV: Impaired impulse propagation in Scn5a- knockout mice: combined contribution of excitability, connexin expression, and tissue architecture in relation to aging. Circulation 112: 1927-1935, 2005. 61.Verdonck F, Volders PG, Vos MA, and Sipido KR:Increased Na+ concentration and altered Na/K pump activity in hypertrophied canine ventricular cells. Cardiovasc Res 57: 1035-1043, 2003. 62.Verkerk AO, Veldkamp MW, Bouman LN, and van Ginneken AC: Calcium-activated Cl- current contributes to delayed afterdepolarizations in single Purkinje and ventricular myocytes. Circulation 101: 2639-2644, 2000. 63.Volders PG, Kulcsar A, Vos MA, Sipido KR, Wellens HJ, Lazzara R, and Szabo B:Similarities between early and delayed afterdepolarizations induced by isoproterenol in canine ventricular myocytes. Cardiovasc Res 34: 348-359, 1997. 64.Waldo AL and Wit AL:Mechanisms of cardiac arrhythmias. Lancet 341: 1189-1193, 1993. 65.Wang DZ, Reiter RS, Lin JL, Wang Q, Williams HS, Krob SL, Schultheiss TM, Evans S, and Lin JJ:Requirement of a novel gene, Xin, in cardiac morphogenesis. Development 126: 1281-1294, 1999. 66.Wang X and Gerdes AM:Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: III. Intercalated disc remodeling. J Mol Cell Cardiol 31: 333-343, 1999. 67.Wang Z, Nolan B, Kutschke W, and Hill JA:Na+-Ca2+ exchanger remodeling in pressure overload cardiac hypertrophy. J Biol Chem 276: 17706-17711, 2001. 68.Wu SH, Chen YC, Higa S and Lin CI:Oscillatory transient inward currents in ventricular myocytes of healthy versus myopathic Syrian hamster. Clin Exp Pharmacol Physiol 31: 668-676, 2004.
|